↓ Skip to main content

Dove Medical Press

Transcranial Direct-Current Stimulation (tDCS) Versus Venlafaxine ER In The Treatment Of Depression: A Randomized, Double-Blind, Single-Center Study With Open-Label, Follow-Up

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
5 X users
facebook
3 Facebook pages

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
35 Mendeley
Title
Transcranial Direct-Current Stimulation (tDCS) Versus Venlafaxine ER In The Treatment Of Depression: A Randomized, Double-Blind, Single-Center Study With Open-Label, Follow-Up
Published in
Neuropsychiatric Disease and Treatment, October 2019
DOI 10.2147/ndt.s226577
Pubmed ID
Authors

Martin Bares, Martin Brunovsky, Pavla Stopkova, Martin Hejzlar, Tomas Novak

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 20%
Researcher 3 9%
Student > Master 3 9%
Student > Doctoral Student 2 6%
Student > Ph. D. Student 2 6%
Other 6 17%
Unknown 12 34%
Readers by discipline Count As %
Medicine and Dentistry 7 20%
Neuroscience 4 11%
Psychology 3 9%
Economics, Econometrics and Finance 1 3%
Agricultural and Biological Sciences 1 3%
Other 4 11%
Unknown 15 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2022.
All research outputs
#7,051,839
of 25,387,668 outputs
Outputs from Neuropsychiatric Disease and Treatment
#889
of 3,131 outputs
Outputs of similar age
#120,540
of 362,793 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#22
of 74 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,793 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.